§ 520.1450c Morantel tartrate sustained-release trilaminate cylinder/sheet.
Primary source
Verbatim text below is from the Electronic Code of Federal Regulations (eCFR), a public-domain U.S. government work. Always verify the current version with the eCFR before relying on it for any legal matter.
Full Text
Specifications.(a) The drug product consists of a trilaminated, perforated, plastic sheet formed into a cylinder having plastic plugs in its ends. The core lamina contains 19.8 grams of morantel tartrate equivalent to 11.8 grams of morantel base.
Sponsor.(b) See 054771 in § 510.600(c) of this chapter.
Related tolerances.(c) See § 556.425 of this chapter.
Conditions of useAmount.(d) —(1) Grazing cattle: Administer 1 cartridge to each animal at the start of the grazing season.
Indications for use.OstertagiaTrichostrongylus axei, CooperiaOesophagostomum radiatum.(2) For control of the adult stage of the following gastrointestinal nematode infections in weaned calves and yearling cattle weighing a minimum of 200 pounds: spp., spp., and
Limitations.(3) Administer orally with the dosing gun to all cattle that will be grazing the same pasture. Effectiveness of the drug product is dependent upon continuous control of the gastrointestinal parasites for approximately 90 days following administration. Therefore, treated cattle should not be moved to pastures grazed in the same grazing season/calendar year by untreated cattle. Do not administer to cattle within 102 days of slaughter. Consult your veterinarian before administering to severely debilitated animals and for assistance in the diagnosis, treatment, and control of parasitism.
[56 FR 13396, Apr. 2, 1991, as amended at 78 FR 28825, May 20, 2014]
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.